ICD 9 Diagnosis Block on Drugs, Medicinal And Biological Substances Causing Adverse Effects In Therapeutic Use (173 entries)
| ICD-9 Code and Description |
|---|
| Chapter: Supplementary Classification Of External Causes Of Injury And Poisoning |
|
E930.0 - Penicillins causing adverse effects in therapeutic use
E930.1 - Antifungal antibiotics causing adverse effects in therapeutic use
E930.2 - Chloramphenicol group causing adverse effects in therapeutic use
E930.3 - Erythromycin and other macrolides causing adverse effects in therapeutic use
E930.4 - Tetracycline group causing adverse effects in therapeutic use
E930.5 - Cephalosporin group causing adverse effects in therapeutic use
E930.6 - Antimycobacterial antibiotics causing adverse effects in therapeutic use
E930.7 - Antineoplastic antibiotics causing adverse effects in therapeutic use
E930.8 - Other specified antibiotics causing adverse effects in therapeutic use
E930.9 - Unspecified antibiotic causing adverse effects in therapeutic use
E931.0 - Sulfonamides causing adverse effects in therapeutic use
E931.1 - Arsenical anti-infectives causing adverse effects in therapeutic use
E931.2 - Heavy metal anti-infectives causing adverse effects in therapeutic use
E931.3 - Quinoline and hydroxyquinoline derivatives causing adverse effects in therapeutic use
E931.4 - Antimalarials and drugs acting on other blood protozoa causing adverse effects in therapeutic use
E931.5 - Other antiprotozoal drugs causing adverse effects in therapeutic use
E931.6 - Anthelmintics causing adverse effects in therapeutic use
E931.7 - Antiviral drugs causing adverse effects in therapeutic use
E931.8 - Other antimycobacterial drugs causing adverse effects in therapeutic use
E931.9 - Other and unspecified anti-infectives causing adverse effects in therapeutic use
E932.0 - Adrenal cortical steroids causing adverse effects in therapeutic use
E932.1 - Androgens and anabolic congeners causing adverse effects in therapeutic use
E932.2 - Ovarian hormones and synthetic substitutes causing adverse effects in therapeutic use
E932.3 - Insulins and antidiabetic agents causing adverse effects in therapeutic use
E932.4 - Anterior pituitary hormones causing adverse effects in therapeutic use
E932.5 - Posterior pituitary hormones causing adverse effects in therapeutic use
E932.6 - Parathyroid and parathyroid derivatives causing adverse effects in therapeutic use
E932.7 - Thyroid and thyroid derivatives causing adverse effects in therapeutic use
E932.8 - Antithyroid agents causing adverse effects in therapeutic use
E932.9 - Other and unspecified hormones and synthetic substitutes causing adverse effects in therapeutic use
E933.0 - Antiallergic and antiemetic drugs causing adverse effects in therapeutic use
E933.1 - Antineoplastic and immunosuppressive drugs causing adverse effects in therapeutic use
E933.2 - Acidifying agents causing adverse effects in therapeutic use
E933.3 - Alkalizing agents causing adverse effects in therapeutic use
E933.4 - Enzymes, not elsewhere classified, causing adverse effects in therapeutic use
E933.5 - Vitamins, not elsewhere classified, causing adverse effects in therapeutic use
E933.6 - Oral bisphosphonates
E933.7 - Intravenous bisphosphonates
E933.8 - Other systemic agents, not elsewhere classified, causing adverse effects in therapeutic use
E933.9 - Unspecified systemic agent causing adverse effects in therapeutic use
E934.0 - Iron and its compounds causing adverse effects in therapeutic use
E934.1 - Liver preparations and other antianemic agents causing adverse effects in therapeutic use
E934.2 - Anticoagulants causing adverse effects in therapeutic use
E934.3 - Vitamin k [phytonadione] causing adverse effects in therapeutic use
E934.4 - Fibrinolysis-affecting drugs causing adverse effects in therapeutic use
E934.5 - Anticoagulant antagonists and other coagulants causing adverse effects in therapeutic use
E934.6 - Gamma globulin causing adverse effects in therapeutic use
E934.7 - Natural blood and blood products causing adverse effects in therapeutic use
E934.8 - Other agents affecting blood constituents causing adverse effects in therapeutic use
E934.9 - Unspecified agent affecting blood constituents causing adverse effects in therapeutic use
E935.0 - Heroin causing adverse effects in therapeutic use
E935.1 - Methadone causing averse effects in therapeutic use
E935.2 - Other opiates and related narcotics causing adverse effects in therapeutic use
E935.3 - Salicylates causing adverse effects in therapeutic use
E935.4 - Aromatic analgesics, not elsewhere classified, causing adverse effects in therapeutic use
E935.5 - Pyrazole derivatives causing adverse effects in therapeutic use
E935.6 - Antirheumatics [antiphlogistics] causing adverse effects in therapeutic use
E935.7 - Other non-narcotic analgesics causing adverse effects in therapeutic use
E935.8 - Other specified analgesics and antipyretics causing adverse effects in therapeutic use
E935.9 - Unspecified analgesic and antipyretic causing adverse effects in therapeutic use
E936.0 - Oxazolidine derivatives causing adverse effects in therapeutic use
E936.1 - Hydantoin derivatives causing adverse effects in therapeutic use
E936.2 - Succinimides causing adverse effects in therapeutic use
E936.3 - Other and unspecified anticonvulsants causing adverse effects in therapeutic use
E936.4 - Anti-parkinsonism drugs causing adverse effects in therapeutic use
E937.0 - Barbiturates causing adverse effects in therapeutic use
E937.1 - Chloral hydrate group causing adverse effects in therapeutic use
E937.2 - Paraldehyde causing adverse effects in therapeutic use
E937.3 - Bromine compounds causing adverse effects in therapeutic use
E937.4 - Methaqualone compounds causing adverse effects in therapeutic use
E937.5 - Glutethimide group causing adverse effects in therapeutic use
E937.6 - Mixed sedatives, not elsewhere classified, causing adverse effects in therapeutic use
E937.8 - Other sedatives and hypnotics causing adverse effects in therapeutic use
E937.9 - Unspecified sedatives and hypnotics causing adverse effects in therapeutic use
E938.0 - Central nervous system muscle-tone depressants causing adverse effects in therapeutic use
E938.1 - Halothane causing adverse effects in therapeutic use
E938.2 - Other gaseous anesthetics causing adverse effects in therapeutic use
E938.3 - Intravenous anesthetics causing adverse effects in therapeutic use
E938.4 - Other and unspecified general anesthetics causing adverse effects in therapeutic use
E938.5 - Surface and infiltration anesthetics causing adverse effects in therapeutic use
E938.6 - Peripheral nerve- and plexus-blocking anesthetics causing adverse effects in therapeutic use
E938.7 - Spinal anesthetics causing adverse effects in therapeutic use
E938.9 - Other and unspecified local anesthetics causing adverse effects in therapeutic use
E939.0 - Antidepressants causing adverse effects in therapeutic use
E939.1 - Phenothiazine-based tranquilizers causing adverse effects in therapeutic use
E939.2 - Butyrophenone-based tranquilizers causing adverse effects in therapeutic use
E939.3 - Other antipsychotics, neuroleptics, and major tranquilizers causing adverse effects in therapeutic use
E939.4 - Benzodiazepine-based tranquilizers causing adverse effects in therapeutic use
E939.5 - Other tranquilizers causing adverse effects in therapeutic use
E939.6 - Psychodysleptics [hallucinogens] causing adverse effects in therapeutic use
E939.7 - Psychostimulants causing adverse effects in therapeutic use
E939.8 - Other psychotropic agents causing adverse effects in therapeutic use
E939.9 - Unspecified psychotropic agent causing adverse effects in therapeutic use
E940.0 - Analeptics causing adverse effects in therapeutic use
E940.1 - Opiate antagonists causing adverse effects in therapeutic use
E940.8 - Other specified central nervous system stimulants causing adverse effects in therapeutic use
E940.9 - Unspecified central nervous system stimulant causing adverse effects in therapeutic use
E941.0 - Parasympathomimetics [cholinergics] causing adverse effects in therapeutic use
E941.1 - Parasympatholytics [anticholinergics and antimuscarinics] and spasmolytics causing adverse effects in therapeutic use
E941.2 - Sympathomimetics [adrenergics] causing adverse effects in therapeutic use
E941.3 - Sympatholytics [antiadrenergics] causing adverse effects in therapeutic use
E941.9 - Unspecified drug primarily affecting the autonomic nervous system causing adverse effects in therapeutic use
E942.0 - Cardiac rhythm regulators causing adverse effects in therapeutic use
E942.1 - Cardiotonic glycosides and drugs of similar action causing adverse effects in therapeutic use
E942.2 - Antilipemic and antiarteriosclerotic drugs causing adverse effects in therapeutic use
E942.3 - Ganglion-blocking agents causing adverse effects in therapeutic use
E942.4 - Coronary vasodilators causing adverse effects in therapeutic use
E942.5 - Other vasodilators causing adverse effects in therapeutic use
E942.6 - Other antihypertensive agents causing adverse effects in therapeutic use
E942.7 - Antivaricose drugs, including sclerosing agents, causing adverse effects in therapeutic use
E942.8 - Capillary-active drugs causing adverse effects in therapeutic use
E942.9 - Other and unspecified agents primarily affecting the cardiovascular system causing adverse effects in therapeutic use
E943.0 - Antacids and antigastric secretion drugs causing adverse effects in therapeutic use
E943.1 - Irritant cathartics causing adverse effects in therapeutic use
E943.2 - Emollient cathartics causing adverse effects in therapeutic use
E943.3 - Other cathartics, including intestinal atonia drugs, causing adverse effects in therapeutic use
E943.4 - Digestants causing adverse effects in therapeutic use
E943.5 - Antidiarrheal drugs causing adverse effects in therapeutic use
E943.6 - Emetics causing adverse effects in therapeutic use
E943.8 - Other specified agents primarily affecting the gastro-intestinal system causing adverse effects in therapeutic use
E943.9 - Unspecified agent primarily affecting the gastrointestinal system causing adverse effects in therapeutic use
E944.0 - Mercurial diuretics causing adverse effects in therapeutic use
E944.1 - Purine derivative diuretics causing adverse effects in therapeutic use
E944.2 - Carbonic acid anhydrase inhibitors causing adverse effects in therapeutic use
E944.3 - Saluretics causing adverse effects in therapeutic use
E944.4 - Other diuretics causing adverse effects in therapeutic use
E944.5 - Electrolytic, caloric, and water-balance agents causing adverse effects in therapeutic use
E944.6 - Other mineral salts, not elsewhere classified, causing adverse effects in therapeutic use
E944.7 - Uric acid metabolism drugs causing adverse effects in therapeutic use
E945.0 - Oxytocic agents causing adverse effects in therapeutic use
E945.1 - Smooth muscle relaxants causing adverse effects in therapeutic use
E945.2 - Skeletal muscle relaxants causing adverse effects in therapeutic use
E945.3 - Other and unspecified drugs acting on muscles causing adverse effects in therapeutic use
E945.4 - Antitussives causing adverse effects in therapeutic use
E945.5 - Expectorants causing adverse effects in therapeutic use
E945.6 - Anti-common cold drugs causing adverse effects in therapeutic use
E945.7 - Antiasthmatics causing adverse effects in therapeutic use
E945.8 - Other and unspecified respiratory drugs causing adverse effects in therapeutic use
E946.0 - Local anti-infectives and anti-inflammatory drugs causing adverse effects in therapeutic use
E946.1 - Antipruritics causing adverse effects in therapeutic use
E946.2 - Local astringents and local detergents causing adverse effects in therapeutic use
E946.3 - Emollients, demulcents, and protectants causing adverse effects in therapeutic use
E946.4 - Keratolytics, keratoplastics, other hair treatment drugs and preparations causing adverse effects in therapeutic use
E946.5 - Eye anti-infectives and other eye drugs causing adverse effects in therapeutic use
E946.6 - Anti-infectives and other drugs and preparations for ear, nose, and throat causing adverse effects in therapeutic use
E946.7 - Dental drugs topically applied causing adverse effects in therapeutic use
E946.8 - Other agents primarily affecting skin and mucous membrane causing adverse effects in therapeutic use
E946.9 - Unspecified agent primarily affecting skin and mucous membrane causing adverse effects in therapeutic use
E947.0 - Dietetics causing adverse effects in therapeutic use
E947.1 - Lipotropic drugs causing adverse effects in therapeutic use
E947.2 - Antidotes and chelating agents, not elsewhere classified, causing adverse effects in therapeutic use
E947.3 - Alcohol deterrents causing adverse effects in therapeutic use
E947.4 - Pharmaceutical excipients causing adverse effects in therapeutic use
E947.8 - Other drugs and medicinal substances causing adverse effects in therapeutic use
E947.9 - Unspecified drug or medicinal substance causing adverse effects in therapeutic use
E948.0 - Bcg vaccine causing adverse effects in therapeutic use
E948.1 - Typhoid and paratyphoid vaccines causing adverse effects in therapeutic use
E948.2 - Cholera vaccine causing adverse effects in therapeutic use
E948.3 - Plague vaccine causing adverse effects in therapeutic use
E948.4 - Tetanus vaccine causing adverse effects in therapeutic use
E948.5 - Diphtheria vaccine causing adverse effects in therapeutic use
E948.6 - Pertussis vaccine, including combinations with a pertussis component, causing adverse effects in therapeutic use
E948.8 - Other and unspecified bacterial vaccines causing adverse effects in therapeutic use
E948.9 - Mixed bacterial vaccines, except combinations with a pertussis component, causing adverse effects in therapeutic use
E949.0 - Smallpox vaccine causing adverse effects in therapeutic use
E949.1 - Rabies vaccine causing adverse effects in therapeutic use
E949.2 - Typhus vaccine causing adverse effects in therapeutic use
E949.3 - Yellow fever vaccine causing adverse effects in therapeutic use
E949.4 - Measles vaccine causing adverse effects in therapeutic use
E949.5 - Poliomyelitis vaccine causing adverse effects in therapeutic use
E949.6 - Other and unspecified viral and rickettsial vaccines causing adverse effects in therapeutic use
E949.7 - Mixed viral-rickettsial and bacterial vaccines, except combinations with a pertussis component, causing adverse effects in therapeutic use
E949.9 - Other and unspecified vaccines and biological substances causing adverse effects in therapeutic use
|